Predictive factors for low rate of remission in a population of Colombian patients with severe proliferative lupus nephritis (Q51063607)

28 March 2018

title

Predictive factors for low rate of remission in a population of Colombian patients with severe proliferative lupus nephritis (English)

1 reference

28 March 2018

author name string

Luis Fernando Pinto-Peñaranda

1 reference

28 March 2018

Vladimir Duque-Caballero

1 reference

28 March 2018

Javier Darío Márquez-Hernández

1 reference

28 March 2018

Carolina Muñoz-Grajales

1 reference

28 March 2018

Carlos Jaime Velásquez-Franco

1 reference

28 March 2018

publication date

17 January 2015

1 reference

28 March 2018

published in

Clinical Rheumatology

1 reference

28 March 2018

volume

1 reference

28 March 2018

issue

1 reference

28 March 2018

page(s)

897-903

1 reference

28 March 2018

The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among "Hispanics".

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2864-7

Epidemiology of systemic lupus erythematosus in a northern Spanish population: gender and age influence on immunological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2864-7

Rapid clinical progression to diagnosis among African-American men with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2864-7

Childhood systemic lupus erythematosus in Latin America. The GLADEL experience in 230 children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2864-7

Retrospective analysis of outcome in a cohort of patients with lupus nephritis treated between 1977 and 1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2864-7

Review: Lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2864-7

Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2864-7

Factors associated with chronic renal failure in 121 patients with diffuse proliferative lupus nephritis: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2864-7

Outcome and prognostic indicators of diffuse proliferative lupus glomerulonephritis treated with sequential oral cyclophosphamide and azathioprine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2864-7

Prognostic factors in lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2864-7

Lupus nephritis in an Afro-Caribbean population: renal indices and clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2864-7

Predictors of relapse and end stage kidney disease in proliferative lupus nephritis: focus on children, adolescents, and young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2864-7

Predictors of chronic kidney disease in Korean patients with lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2864-7

Factors associated with poor outcomes in patients with lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2864-7

Risk factors for renal failure in patients with lupus nephritis: data from the spanish registry of glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2864-7

Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2864-7

Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2864-7

Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2864-7

Value of a complete or partial remission in severe lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2864-7

Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2864-7

Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2864-7

The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials

21 January 2018

1 reference

12 December 2020

Progression and remission of renal disease in the Lupus Nephritis Collaborative Study. Results of treatment with prednisone and short-term oral cyclophosphamide

1 reference

12 December 2020

Response to treatment as a predictor of longterm outcome in patients with lupus nephritis

1 reference

12 December 2020

Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group

1 reference

12 December 2020

Systemic lupus erythematosus in a multiethnic US cohort: Clinical features, course, and outcome in patients with late-onset disease

1 reference

12 December 2020

Lupus nephritis: a retrospective review of 78 cases from a single center.

1 reference

12 December 2020

High-risk features of lupus nephritis: importance of race and clinical and histological factors in 166 patients

1 reference

12 December 2020

Predictive value of remission status after 6 months induction therapy in patients with proliferative lupus nephritis: a retrospective analysis

1 reference

12 December 2020

10.1007/S10067-015-2864-7

Identifiers

DOI

1 reference

28 March 2018

1 reference

28 March 2018